Sun, Sun http://orcid.org/0000-0001-5948-3025
Jonsson, Håkan http://orcid.org/0000-0002-4295-4801
Salén, Klas-Göran http://orcid.org/0000-0002-3975-4868
Andén, Mats
Beckman, Lars http://orcid.org/0000-0001-6684-6816
Fransson, Per http://orcid.org/0000-0002-1248-5581
Funding for this research was provided by:
Lion's Cancer Research Foundation (LP 17-2146)
Prostatacancerförbunde
Umea University
Article History
Received: 27 August 2021
Accepted: 12 April 2022
First Online: 19 May 2022
Declarations
:
: The authors declare that they have no conflict of interest.
: The study was approved in Sweden by the Ethics Committee in Umeå (reference number 03-513, 2003-12-23) and in Denmark by the Central Denmark Region Committees on Health Research Ethics (M-20090180, 2009-11-19).
: All patients provided written and verbal informed consent for participating in the clinical trial, details can be found in the study protocol online (ExternalRef removed). It is registered at the ISRCT register (Trial no: ISRCTN45905321, ExternalRef removed). Information for costs were retrieved from the existing register. The registers are regulated by the General Data Protection Regulation (GDPR) in Sweden since 25 May 2018. The Central Personal Data Controller (CPDA) is the health authority who is responsible for the overall data security of the registers in Sweden. Participation of any register is voluntary, and the participants has been informed about registration of their information. The participant also has the right to get a register extract of their personal data, incorrect information can be corrected, and deletion may take place upon request.
: All patients have been informed and agreed on that the study results will be based on group level on scientific journals and conferences.